Modified Bristow-Latarjet procedure for treatment of recurrent traumatic anterior glenohumeral dislocation

Abstract

ObjectiveRetrospective case–control study of authors experience in the modified Bristow-Latarjet procedure for treatment of recurrent traumatic anterior glenohumeral dislocation with glenoid bone injury.MethodsSample with 102 recurrent glenohumeral dislocation cases submitted to modified Bristow-Latarjet procedure. Indications included situations of recurrent traumatic anterior glenohumeral instability with more than two dislocation episodes and with glenoid bone attritional or fragmentary injuries, without possibility of reconstruction. Mean follow-up time was 5.33 ± 2.74 years (minimum 1; range 1–13).ResultsThe mean Walch-Duplay Score at the last evaluation was 91.23 ± 11.46 (range 15–100). The functional score of patients with glenoid bone loss greater than 20% did not show a significant difference in comparison with patients with glenoid bone loss lower than 20% (90 vs. 92, respectively). The functional score also did not show a significant difference between sports practice categories and between recreational and competitive practice, being excellent (greater than 90) in every category. There were no dislocation recurrences and the only complications were a case of persistent instability and a screw revision. Mild glenohumeral osteoarthrosis imaging signs were identified in 7.84% of the patients; however, their functional scores were not significantly different in comparison to other patients.ConclusionThe modified Bristow-Latarjet procedure is a very effective procedure with few complications in the medium-term, showing very satisfactory functional outcomes in the treatment of recurrent traumatic anterior glenohumeral dislocation associated with glenoid bone injury.

Biomechanical Comparison of the Long Head of the Biceps Tendon Versus Conjoint Tendon Transfer in a Bone Loss Shoulder Instability Model

“…9,11 Several open and arthroscopic operative techniques are utilized to reconstruct the glenoid with a variety of autograft and allograft sources. 1 –3,12 –14,16,20 –23,34 The Bristow-Latarjet procedure is being used with increasing frequency for addressing recurrent shoulder instability in the setting of glenoid bone loss. This surgical technique restores the congruity of the deficient glenoid by augmenting the anterior glenoid with the coracoid process.…”

Avaliação do perfil demográfico e do estado funcional pós cirurgia de Latarjet em pacientes com luxação redicivante do ombro

“…Assim como o que foi constatado neste estudo, Carrazzone OL, et al (2010) avaliou a prevalência de pacientes com quadro de luxação recidivante do ombro em uma população específica e notou a prevalência de paciente jovens com menos de 40 anos de idade, apresentando a média de 27 anos e, em sua maioria, não praticantes de atividade esportiva. Moura DL, et al (2018), em seu estudo, observou que o tratamento cirúrgico de pacientes com esta afecção por meio do uso da técnica de Latarjet, apresentou um excelente resultado funcional com maior segurança para retorno às atividades laborais e atividades esportivas de contato sem relato de recidiva do quadro, demonstrando um desfecho satisfatório.…”

“…É composta pela face articular da glenóide, em formato côncavo, e pela face articular da porção proximal do úmero, em formato esférico e convexo. Entre as faces articulares existe um espaço virtual, ou seja, constituído por pequena quantidade de líquido sinovial (BAKHSH W e NICANDRI G, 2018; MOURA DL, et al, 2018).…”

Incidência e fatores de risco das complicações da cirurgia de Latarjet

“…Although the literature is clear in showing consistent joint stabilization results, few studies report the risk factors and incidence of Latarjet complications, which ranges from 0 to 30%. [2][3][4][5][6][7][8][9][10][11][12] The most frequently reported complications include neurological injury, infection, instability recurrence, fracture and graft pseudoarthrosis. In addition, the treatment of these complications often requires a surgical revision.…”